Effect of quercetin on Hepatitis C virus life cycle: From viral to host targets

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Rojas, Ngela ^a,b   Del Campo, Jose A ^b   Clement, Sophie ^c   Lemasson, Matthieu ^d   García Valdecasas, Marta ^a,b   Gil Gómez, Antonio ^a,b   Ranchal, Isidora ^b   Bartosch, Birke ^e   Bautista, Juan D ^f   Rosenberg, Arielle R ^d   Negro, Francesco ^c   Romero Gómez, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^f UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL ACYLTRANSFERASE; FAT DROPLET; QUERCETIN;

CELL CULTURE; DRUG EFFECT; GENE EXPRESSION; GENETICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIRION; VIROLOGY; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELLS, CULTURED; DIACYLGLYCEROL O-ACYLTRANSFERASE; GENE EXPRESSION; HEPACIVIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPID DROPLETS; LIVER NEOPLASMS; QUERCETIN; VIRION; VIRUS REPLICATION;

EID: 84983441889     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31777     Document Type: Article

References (48)

1. Reed, K. E., & Rice, C. M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Current Topics in Microbiol Immunol 242, 55-84 (2000).
2. Smith, D. B., et al. Expanded classification of hepatitis C virus into 7 genotypes, and 67 subtypes: updated criteria, and genotype assignment web resource. Hepatology 59(1), 318-327 (2014).
3. Negro, F. Abnormalities of lipid metabolism in hepatitis C virus infection. Gut 59(9), 1279-87 (2010).
4. Del Campo, J. A., & Romero-Gómez, M. Steatosis, and insulin resistance in hepatitis C: A way out for the virus? World J Gastroenterol 15, 5014-5019 (2009).
5. André, P., et al. Characterization of low-, and very-low-density hepatitis C virus RNA-containing particles. J Virol 76, 6919-6928 (2002).
6. Bradley, D., et al. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J. Med. Virol 34(3), 206-208 (1991).
7. Sainz, B. Jr., et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18, 281-285 (2012).
8. Dubuisson, J., & Cosset, F. L. Virology, and cell biology of the hepatitis C virus life cycle: an update. J Hepatol. 61, S3-S13.
9. Miyanari, Y., et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9, 1089-1097 (2007).
10. Barba, G., et al. Hepatitis C virus core protein shows a cytoplasmic localization, and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94, 1200-1205 (1997).
11. Boulant, S., et al. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule-, and dynein-dependent manner. Traffic 9(8), 1268-1282 (2008).
12. Herker, E., et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16, 1295-1298 (2010).
13. Bartenschlager, R., Penin, F., Lohmann, V., & André, P. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 19, 95-103 (2011).
14. Webster, D. P., Klenerman, P., Dusheiko, G. M., & Hepatitis C. Lancet 385(9973), 1124-1135 (2015).
15. Kowdley, K. V., et al. Ledipasvir, and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med 370(20), 1879-1888 (2014).
16. Chhatwal, J., He, T., & Lopez-Olivo, M. A. Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals. Pharmacoeconomics 9, [Epub ahead of print] (2016).
17. Liu, M. M., et al. Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy. Eur J Med Chem 52, 33-43 (2012).
18. Bravo, L. Polyphenols; chemistry, dietary sources, metabolism, and nutritional significance. Nutri Rev 56, 317-333 (1998).
19. Gonzalez, O., et al. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology 50, 1756-1764 (2009).
20. Bachmetov, L., et al. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepat 19, e81-e88 (2012).
21. Lulu, S. S., Thabitha, A., Vino, S., Priya, A. M., & Rout, M. Naringenin, and quercetin-potential anti-HCV agents for NS2 protease targets. Nat Prod Res 16, 1-5 (2015).
22. Khachatoorian, R., et al. Divergent antiviral effects of bioflavonoids on the hepatitis C virus life-cycle. Virology 433, 346-355 (2012).
23. Bhattacharya, D., Ansari, I. H., Mehle, A., & Striker, R. Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A. J Virol 86, 8277-8286 (2012).
24. Prior, R. L. Fruits, and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr 78, 570S-578S (2003).
25. Formica, J. V., & Regelson, W. Review of the biology of quercetin, and related bioflavonoids. Food Chem Toxicol 33, 1061-1080 (1995).
26. Gnoni, G. V., Paglialonga, G., & Siculella, L. Quercetin inhibits fatty acid, and triacylglycerol synthesis in rat-liver cells. Eur J Clin Invest 39, 761-768 (2009).
27. Casaschi, A., Wang, Q., Dang, K., Richards, A., & Theriault, A. Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein, and diacylglycerol acyltransferase Lipids 37, 647-652 (2002).
28. Lu, N. T., et al. A Phase I Dose Escalation Study Demonstrates Quercetin Safety, and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C. Phytother Res 30(1), 160-168 (2016).
29. Podevin, P., et al. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139, 1355-1364 (2010).
30. Rojas, Á., et al. Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism, and viral genotype, and modulates gene expression in vivo, and in vitro. J Viral Hepat. 21(1), 19-24 (2014).
31. Theriault, A., et al. Modulation of hepatic lipoprotein synthesis, and secretion by taxifolin, a plant flavonoid. J Lipid Res 41, 1969-1979 (2000).
32. Wilcox, L. J., Borradaile, N. M., de Dreu, L. E., & Huff, M. W. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin, and hesperetin, via reduced activity, and expression of ACAT2, and MTP. J Lipid Res 42, 725-734 (2001).
33. Costin-Ioan, P., Rouillé, Y., Dubuisson, J., & Hepatitis C. Virus Assembly Imaging. Viruses 3(11), 2238-2254 (2011).
34. Kaul, T. N., Middleton, E. Jr., & Ogra, P. L. Antiviral effect of flavonoids on human viruses. J Med Virol 15, 71-79 (1985).
35. Davis, J. M., Murphy, E. A., McClellan, J. L., Carmichael, M. D., & Gangemi, J. D. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am J Physiol Regul Integr Comp Physiol 295, R505-509 (2008).
36. Chiang, L. C., Chiang, W., Liu, M. C., & Lin, C. C. In vitro antiviral activities of Caesalpinia pulcherrima, and its related flavonoids. J Antimicrob Chemother 52, 194-198 (2003).
37. Kobori, M., Masumoto, S., Akimoto, Y., & Oike, H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res 55, 530-540 (2011).
38. Yen, C. L., Stone, S. J., Koliwad, S., Harris, C., & Farese, R. V. Jr. Thematic review series: glycerolipids. DGAT enzymes, and triacylglycerol biosynthesis. J Lipid Res 49(11), 2283-2301 (2008).
39. Calland, N., et al. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. J Virol 89(19), 10053-10063 (2015).
40. Wakita, T., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11(7), 791-796 (2005).
41. Pietschmann, T., et al. Construction, and characterization of infectious intragenotypic, and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103(19), 7408-7413 (2006).
42. Carrière, M., et al. A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. J Med Virol 79(2), 155-160 (2007).
43. Pène, V., Hernandez, C., Vauloup-Fellous, C., Garaud-Aunis, J., & Rosenberg, A. R. Squential processing of hepatitis C virus core protein by host cell signal peptidase, and signal peptide peptidase: a reassessment. J Viral Hepat 16, 705-715 (2009).
44. Chomczynski, P., & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162, 156-159 (1987).
45. Bartosch, B., Dubuisson, J., & Cosset, F. L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197(5), 633-642 (2003).
46. Clement, S., et al. Role of seipin in lipid droplet morphology, and hepatitis C virus life cycle. The Journal of general virology 94, 2208-2214 (2013).
47. McFie Pamela, J., & Stone Scot, J. A fluorescent assay to quantitatively measure in vitro acyl CoA:diacylglycerol acyltransferase activity. J Lipid Res 52, 1760-1764 (2011).
48. Clement, S., et al. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes. Hepatology 48, 799-807 (2008).